Literature DB >> 23472729

The cost of materials for intra-arterial thrombectomy.

F Bing1, G Jacquin, A Poppe, D Roy, J Raymond, A Weill.   

Abstract

This paper reports the cost of endovascular materials used for the treatment of large-vessel ischemic stroke in the anterior circulation according to the angiographic score and clinical results at three months. From November 2009 to July 2011, 57 ischemic patients (mean age, 64.6 ±13.8 years) with anterior large vessel occlusion were included. Mean National Institutes of Health Stroke Scale (NIHSS) on admission was 18.4 ± 4.9. Mean duration of symptoms until the arterial puncture was 207±67 minutes. Recanalization was assessed using the Thrombolysis In Myocardial Infarction (TIMI) score. Patient selection was performed on a non-enhanced CT scanner. According to the TIMI final angiographic score and the modified Rankin score (mRS) at three months, we determined the cost of the material used. Complete (n=12, TIMI grade 3) or partial perfusion (n=35, TIMI grade 2) was achieved in 47 (82.5%) lesions. At three months, 33.3% (n=19) had a mRS score ≤ 2. The mean cost of the material used in the operative room was 5018±2402 euro. Intra-arterial thrombolysis presents a substantial initial cost and the long-term economic impact has to be evaluated. Our health system has to take the price of these new technologies into account for future medical choices and urgently evaluate them in randomized controlled trials.

Entities:  

Mesh:

Year:  2013        PMID: 23472729      PMCID: PMC3601624          DOI: 10.1177/159101991301900113

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  29 in total

1.  A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke.

Authors:  Anthony S Kim; Mai Nguyen-Huynh; S Claiborne Johnston
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

Review 2.  Stroke centers: proof of concept and the concept of proof.

Authors:  Mark J Alberts
Journal:  Stroke       Date:  2010-04-15       Impact factor: 7.914

3.  Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.

Authors:  Lars Ehlers; Grethe Andersen; Lone Beltoft Clausen; Merete Bech; Mette Kjølby
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

4.  Barriers and facilitators to implementing primary stroke center policy in the United States: results from 4 case study states.

Authors:  Laurence J O'Toole; Catherine P Slade; Gene A Brewer; Lauren N Gase
Journal:  Am J Public Health       Date:  2011-01-13       Impact factor: 9.308

5.  Cost-effectiveness analysis of thrombolytic treatment for stroke.

Authors:  Javier Mar; Jose Maria Begiristain; Arantza Arrazola
Journal:  Cerebrovasc Dis       Date:  2005-07-27       Impact factor: 2.762

6.  Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective.

Authors:  S E Sinclair; L Frighetto; P S Loewen; R Sunderji; P Teal; S C Fagan; C A Marra
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 7.  Rehabilitation after stroke: cost-effectiveness analyses.

Authors:  R A Keith
Journal:  J R Soc Med       Date:  1996-11       Impact factor: 18.000

8.  Cost-effectiveness of stroke unit care followed by early supported discharge.

Authors:  Omer Saka; Victoria Serra; Yevgeniy Samyshkin; Alistair McGuire; Charles C D A Wolfe
Journal:  Stroke       Date:  2008-11-13       Impact factor: 7.914

9.  The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life.

Authors:  Javier Mar; Arantzazu Arrospide; José María Begiristain; Isabel Larrañaga; Elena Elosegui; Juan Oliva-Moreno
Journal:  BMC Neurol       Date:  2011-04-18       Impact factor: 2.474

10.  Cost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: a systematic review.

Authors:  Kee-Taig Jung; Dong Wook Shin; Kyung-Jin Lee; Myungju Oh
Journal:  J Clin Neurol       Date:  2010-09-30       Impact factor: 3.077

View more
  1 in total

1.  Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.